Exane Derivatives’s XPO XPO Stock Holding History

Exane Derivatives’s Portfolio XPO Stock Details XPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$146	–	1029
2022 Q1	$146	Buy	+3	New	+$125	﹤0.01%	977
2021 Q4	–	Sell	-61	Closed	-$2.87K	–	1078
2021 Q3	$2.87K	Sell	61 -43	-41%	-$2.15K	﹤0.01%	774
2021 Q2	$5.11K	Sell	104 -1,110	-91%	-$54.2K	﹤0.01%	772
2021 Q1	$51.8K	Buy	+1,214	New	+$50.4K	0.01%	513

Other funds holding XPO

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ACM

Anomaly Capital Management New York $2.62B AUM 23.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Exane Derivatives's XPO Position: Q2 2022 in Review

Exane Derivatives sold out of XPO (XPO) in Q2 2022, closing a stake of 3 shares — an estimated $146 sold.

Exane Derivatives first reported a position in XPO in Q1 2021 and held it in 4 quarters. The position peaked at $51.8K in Q1 2021. 437 funds tracked by Wall St. Rank hold XPO as of Q2 2022.

Exane Derivatives reported no remaining XPO position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 3 XPO shares in Q2 2022, an estimated $146.
Exane Derivatives first reported a position in XPO in Q1 2021 and held it in 4 quarters.
Exane Derivatives's XPO position peaked at $51.8K in Q1 2021.
437 funds tracked by Wall St. Rank held XPO as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.